en
Scientific article
English

Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism

Published inTherapeutische Umschau, vol. 73, no. 10, p. 618-625
Publication date2016
Keywords
  • Administration
  • Oral
  • Anticoagulants/adverse effects/pharmacokinetics/therapeutic use
  • Clinical Trials
  • Phase III as Topic
  • Dabigatran/adverse effects/pharmacokinetics/therapeutic use
  • Dose-Response Relationship
  • Drug
  • Drug Administration Schedule
  • Hemorrhage/blood/chemically induced
  • Humans
  • International Normalized Ratio
  • Pulmonary Embolism/blood/drug therapy
  • Pyrazoles/adverse effects/pharmacokinetics/therapeutic use
  • Pyridines/adverse effects/pharmacokinetics/therapeutic use
  • Pyridones/adverse effects/pharmacokinetics/therapeutic use
  • Rivaroxaban/adverse effects/pharmacokinetics/therapeutic use
  • Thiazoles/adverse effects/pharmacokinetics/therapeutic use
  • Venous Thromboembolism/blood/drug therapy
  • Vitamin K/antagonists & inhibitors
Citation (ISO format)
ROBERT-EBADI, Helia, RIGHINI, Marc Philip. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism. In: Therapeutische Umschau, 2016, vol. 73, n° 10, p. 618–625. doi: 10.1024/0040-5930/a000833
Identifiers
ISSN of the journal0040-5930
398views
0downloads

Technical informations

Creation08/30/2017 1:46:00 PM
First validation08/30/2017 1:46:00 PM
Update time03/15/2023 2:24:50 AM
Status update03/15/2023 2:24:50 AM
Last indexation01/17/2024 1:28:24 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack